HPV-16 E7 lipopeptide vaccine (Tufts University School of Medicine)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHPV-16 E7 lipopeptide vaccine (Tufts University School of Medicine)

Drug Alias NameHPV-16 E7 lipopeptide vaccine

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPapillomavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTufts University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTufts University

Active IndicationsN/A

Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A